Treace Medical Concepts, Inc. (TMCI)
4.63
-0.18
(-3.74%)
USD |
NASDAQ |
Sep 08, 16:00
4.645
+0.02
(+0.32%)
After-Hours: 20:00
Treace Medical Concepts Shareholders Equity (Quarterly) : 67.74M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 67.74M |
| March 31, 2026 | 77.19M |
| December 31, 2025 | 87.33M |
| September 30, 2025 | 89.19M |
| June 30, 2025 | 97.62M |
| March 31, 2025 | 105.34M |
| December 31, 2024 | 112.89M |
| September 30, 2024 | 104.91M |
| June 30, 2024 | 112.14M |
| March 31, 2024 | 126.39M |
| December 31, 2023 | 137.94M |
| September 30, 2023 | 137.86M |
| June 30, 2023 | 149.96M |
| March 31, 2023 | 157.62M |
| Date | Value |
|---|---|
| December 31, 2022 | 60.53M |
| September 30, 2022 | 62.20M |
| June 30, 2022 | 71.71M |
| March 31, 2022 | 86.82M |
| December 31, 2021 | 93.07M |
| September 30, 2021 | 97.37M |
| June 30, 2021 | 102.91M |
| March 31, 2021 | -0.684M |
| December 31, 2020 | 0.776M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 3.161M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tactile Systems Technology, Inc. | 223.84M |
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 181.06M |
| Total Liabilities (Quarterly) | 113.32M |
| Debt to Equity Ratio | 1.078 |
| Current Ratio | 2.903 |
| Net Debt Paydown Yield | -0.28% |